Towards Healthcare
Europe Cell and Gene Therapy Market to Rise at 23.90% CAGR till 2034

Europe Cell and Gene Therapy Market Government Funding and EMA Approvals

According to forecasts, the Europe cell and gene therapy market will grow from USD 2.74 billion in 2024 to USD 48.96 billion by 2034, with an expected CAGR of 23.90%. The Europe cell and gene therapy market is growing due to the growing incidence of genetic diseases and enhanced regulatory frameworks.

Content

  • Last Updated: 13 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The Europe cell and gene therapy market is worth USD 7.17 billion in 2025, and by 2034, it is forecasted to hit USD 48.96 billion, registering a CAGR of 23.90% over the decade.

Germany is currently leading the Europe cell and gene therapy market share by 28% due to a strong infrastructure and robust public and private investment in research and development.

The Europe cell and gene therapy market includes five segments: by therapy type, by therapeutic area, by vector type, by cell source, by manufacturing scale, by end user, and by region.

WHO, FDA, National Institutes of Health, NHS, GOV.UK.
Any Questions